Key Financial Data Of Group

WAKAMOTO PHARMACEUTICAL CO.,LTD. - Filing #7349984

Concept As at
2023-12-31
2023-10-01 to
2023-12-31
2023-04-01 to
2023-12-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-12-31
2022-04-01 to
2022-12-31
2022-10-01 to
2022-12-31
Key financial data of group
Business results of group
Net sales
5,586,399,000 JPY
8,660,379,000 JPY
6,267,995,000 JPY
Ordinary profit (loss)
-225,955,000 JPY
242,574,000 JPY
128,994,000 JPY
Net assets
11,701,447,000 JPY
11,906,669,000 JPY
11,767,859,000 JPY
Total assets
15,254,898,000 JPY
15,711,553,000 JPY
15,143,578,000 JPY
Basic earnings (loss) per share
0.50
-5.92
3.98
3.18
3.80
Diluted earnings per share
Equity-to-asset ratio
0.7671 xbrli:pure
0.7578 xbrli:pure
0.7770 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.